Vol. 221, No. 11 | https://doi.org/10.1084/jem.20231193 | September 25, 2024

The authors regret that, throughout the article, the Mx1GFP strain was accidentally labeled as transgenic (tg). Instead, it is the Mx1Cre strain that is transgenic. The Mx1GFP strain is a reporter from the endogenous locus, and the Mx1Cre strain is a transgene. Therefore, tgMx1GFP has been changed to Mx1GFP and Mx1Cre has been changed to tgMx1Cre throughout the article, including within Fig. 3 j. In the Results, the sixth paragraph of the “A pTCM differentiation pathway ... ” section has been reworded, with the changes shown in bold below. This correction does not change the original conclusions of the article. The errors appear in print and in PDFs downloaded before October 15, 2024.

A pTCM differentiation pathway arising from naïve CD4+ T cells(sixth paragraph)

To experimentally validate the temporal correlation between cells that have received IFN signaling and cells that end up in the TCM lineage, we generated dual reporter and fate-mapper mice by breeding the Mx1GFP mice reporting on Mx1 transcription from the endogenous locus (Uccellini and García-Sastre, 2018) with the transgenic Mx1Cre mice (Kühn et al., 1995) and with mice harboring a Rosa26lox-STOP-lox-tdTomato recombination reporter allele, in which tdTomato (tdT) expression irreversibly tags cells that have received a type I IFN signal. Mx1GFP × tgMx1CreRosa26lsl-tdT mice were infected with L.m.-gp66 and assessed for history of IFN signaling (i.e., Mx1 expression) in antigen-specific CD4+ T cells identified using LLO:I-Ab or gp66:I-Ab tetramers on day 7 after infection (Fig. 3 j). It is noteworthy that the Mx1 transcript was not one of the top differentially expressed genes (DEGs) within the signature ISG gene set. Therefore, Mx1GFP expression likely faithfully reports on cells experiencing the strongest type I IFN signal as noted in the original study (Uccellini and García-Sastre, 2018) rather than reflecting low tonic signaling or potential spurious expression of some ISGs in T cells. This analysis revealed an increased frequency of Mx1 fate-mapped cells amongst CD62L+ pTCM cells relative to their TFH or TH1 counterparts (Fig. 3, k and l), confirming the predicted trajectory identified earlier in which cells receiving type I IFN signals adopt a pTCM fate.

This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).